{
    "nctId": "NCT02734173",
    "officialTitle": "Pilot Evaluation of the Influence of ABT450r, Ombitasvir, Dasabuvir +/- Ribavirin HCV Therapy on Insulin Resistance and Lipid Profile",
    "inclusionCriteria": "* HCV RNA evidence of HCV infection\n* Documented history of chronic HCV RNA infection with Genotype 1\n* Able to provide informed consent\n* Available for ongoing follow-up if required\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* \\<18 years old\n* Evidence of decompensated liver disease\n* HOMA IR\\< 2.0\n* HIV seropositivity\n* Chronic HBV/HIV infection\n* Use of immune suppressing medications\n* Active malignancy"
}